10 C.F.R. § 35.15

Exemptions regarding Type A specific licenses of broad scope.

Last amended: 2019Year: 2026Length: 145 wordsSubsections: 7Official source

Cite as 10 C.F.R. § 35.15 (2026)

A licensee possessing a Type A specific license of broad scope for medical use, issued under Part 33 of this chapter, is exempt from— (a) The provisions of § 35.12(d) regarding the need to file an amendment to the license for medical use of byproduct material, as described in § 35.1000; (b) The provisions of § 35.13(b); (c) The provisions of § 35.13(f) regarding additions to or changes in the areas of use at the addresses identified in the application or on the license; (d) The provisions of § 35.14(a); (e) The provisions of § 35.14(b)(1) for an authorized user, an authorized nuclear pharmacist, an authorized medical physicist, or an ophthalmic physicist; (f) The provisions of § 35.14(b)(5). (g) The provisions of § 35.49(a). [67 FR 20370, Apr. 24, 2002, as amended at 72 FR 55931, Oct. 1, 2007; 83 FR 33103, July 16, 2018]
Cross-references to the CFR
35.100035.1235.1335.1435.49
10 C.F.R. § 35.15: Exemptions regarding Type A specific licenses of broad scope. | Justis AI